TG and neoplasm: Theoretically, 131I therapy is thought to reduce the recurrence and mortality rate in DTC patients by destroying microscopic residual tumor foci, which also facilitates early detection of recurrence by enhancing the sensitivity and reliability of serum thyroglobulin (Tg) and 131I whole-body scan (WBS)5, 6, 7.